A detailed history of Quadrature Capital LTD transactions in Nkarta, Inc. stock. As of the latest transaction made, Quadrature Capital LTD holds 37,289 shares of NKTX stock, worth $69,730. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,289
Holding current value
$69,730
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$1.67 - $2.37 $62,272 - $88,374
37,289 New
37,289 $77.4 Million

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $91M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Quadrature Capital LTD Portfolio

Follow Quadrature Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrature Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Quadrature Capital LTD with notifications on news.